Lanzavecchia A - Search Results

1

Janusin: new molecular design for bispecific reagents.

Traunecker A, Lanzavecchia A, Karjalainen K. Traunecker A, et al. Among authors: lanzavecchia a. Int J Cancer Suppl. 1992;7:51-2. Int J Cancer Suppl. 1992. PMID: 1428404 Review.

2

Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes.

Lane P, Traunecker A, Hubele S, Inui S, Lanzavecchia A, Gray D. Lane P, et al. Among authors: lanzavecchia a. Eur J Immunol. 1992 Oct;22(10):2573-8. doi: 10.1002/eji.1830221016. Eur J Immunol. 1992. PMID: 1382991

3

Adoptive immunotherapy of ovarian carcinoma with bs-MAb-targeted lymphocytes: a multicenter study.

Bolhuis RL, Lamers CH, Goey SH, Eggermont AM, Trimbos JB, Stoter G, Lanzavecchia A, di Re E, Miotti S, Raspagliesi F, et al. Bolhuis RL, et al. Among authors: lanzavecchia a. Int J Cancer Suppl. 1992;7:78-81. Int J Cancer Suppl. 1992. PMID: 1428412 Clinical Trial.

4

Bispecific single chain molecules (Janusins) target cytotoxic lymphocytes on HIV infected cells.

Traunecker A, Lanzavecchia A, Karjalainen K. Traunecker A, et al. Among authors: lanzavecchia a. EMBO J. 1991 Dec;10(12):3655-9. doi: 10.1002/j.1460-2075.1991.tb04932.x. EMBO J. 1991. PMID: 1834458 Free PMC article.

5

T cell activation by a bispecific anti-CD3/anti-major histocompatibility complex class I antibody.

Roosnek E, Tunnacliffe A, Lanzavecchia A. Roosnek E, et al. Among authors: lanzavecchia a. Eur J Immunol. 1990 Jun;20(6):1393-6. doi: 10.1002/eji.1830200627. Eur J Immunol. 1990. PMID: 2142461

6

Triggering T cells by otherwise inert hybrid anti-CD3/antitumor antibodies requires encounter with the specific target cell.

Roosnek E, Lanzavecchia A. Roosnek E, et al. Among authors: lanzavecchia a. J Exp Med. 1989 Jul 1;170(1):297-302. doi: 10.1084/jem.170.1.297. J Exp Med. 1989. PMID: 2526194 Free PMC article.

7

In vivo localization of a bispecific antibody which targets human T lymphocytes to lyse human colon cancer cells.

Barr IG, Miescher S, von Fliedner V, Buchegger F, Barras C, Lanzavecchia A, Mach JP, Carrel S. Barr IG, et al. Among authors: lanzavecchia a. Int J Cancer. 1989 Mar 15;43(3):501-7. doi: 10.1002/ijc.2910430327. Int J Cancer. 1989. PMID: 2647641

8

T cells can present antigens such as HIV gp120 targeted to their own surface molecules.

Lanzavecchia A, Roosnek E, Gregory T, Berman P, Abrignani S. Lanzavecchia A, et al. Nature. 1988 Aug 11;334(6182):530-2. doi: 10.1038/334530a0. Nature. 1988. PMID: 2841610

9

Human ovarian carcinoma lysis by cytotoxic T cells targeted by bispecific monoclonal antibodies: analysis of the antibody components.

Mezzanzanica D, Canevari S, Ménard S, Pupa SM, Tagliabue E, Lanzavecchia A, Colnaghi MI. Mezzanzanica D, et al. Among authors: lanzavecchia a. Int J Cancer. 1988 Apr 15;41(4):609-15. doi: 10.1002/ijc.2910410422. Int J Cancer. 1988. PMID: 3258590

10

T-helper- and accessory-cell-independent cytotoxic responses to human tumor cells transfected with a B7 retroviral vector.

Döhring C, Angman L, Spagnoli G, Lanzavecchia A. Döhring C, et al. Among authors: lanzavecchia a. Int J Cancer. 1994 Jun 1;57(5):754-9. doi: 10.1002/ijc.2910570524. Int J Cancer. 1994. PMID: 7515023

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

397 results

Search Page

Filters